|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:285-291
© 1999 Mosby, Inc.
SURGERY FOR ADULT CARDIOVASCULAR DISEASE |
From the Departments of Cardiothoracic Surgery,a Anesthesiology,b Histology,c and Neurophysiology,d University of Vienna, Vienna, Austria.
This work was supported by grant 5713 from the Austrian National Bank and by Dr H. Kolassa and Merz, Vienna, Austria.
Read at the Seventy-eighth Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 3-6, 1998.
Received for publication May 8, 1998. Revisions requested Aug 6, 1998; revisions received Sept 18, 1998. Accepted for publication Oct 8, 1998. Address for reprints: Marek Ehrlich, MD, Department of Cardio-Thoracic Surgery, Mount Sinai Medical Center, One Gustave Levy Place, Box 1028, New York, NY 10029.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Evidence is gathering that excitatory amino acid neurotransmission may contribute to neuronal cell death.
9,10 Glutamate, the most important excitatory amino acid, is potentially toxic to central nervous tissue through activation of postsynaptic N-methyl-D-aspartate (NMDA) receptors and the subsequent induction of excessive calcium ion influx, which leads to neuronal cell death.
11 NMDA antagonists have been proved to reduce spinal cord injury after ischemia.
12
The noncompetitive NMDA receptor antagonist memantine is known to attenuate hypoxic or ischemic damage to spinal neurons.
13 This study elucidates the effect of memantine on the neurologic outcome of spinal cord ischemia and reperfusion injury related to aortic occlusion in the rabbit model. The rabbit was used because of its unique segmental arterial blood supply to the spinal cord from the infrarenal aorta.
14 The primary interest was to compare each treated group with the control group.
| Materials and methods |
|---|
|
|
|---|
Twenty-four New Zealand White rabbits (3.4-4.3 kg) were randomly split into 3 groups. In the control group of 8 animals (group 1), crossclamping of the infrarenal aorta was performed without intervention. In 8 rabbits (group 2) a 24-gauge catheter was inserted into the aorta distal to the proximal clamp and memantine was infused with an infusion pump (20 mg/kg memantine in 15 mL sodium chloride at 5 mL/min) into the isolated aortic segment. After the infusion the aortic catheter was removed and the arteriotomy was closed with a 7-0 polypropylene suture. The third group included 8 animals (group 3) that were treated with a systemic memantine infusion (20 mg/kg memantine in 30 mL sodium chloride at 1 mL/min) 45 minutes before aortic occlusion. All animals were anesthetized intramuscularly with 25 mg/kg ketamine, 2.5 mg/kg xylazine, and 0.06 mg/kg atropine.
After intubation, controlled ventilation (Servo 900; Siemens-Elema, Solna, Sweden) was started with 8 mL/kg of 50% oxygen mixed with air at a respiratory rate of 30 breaths/min. Ketamine was infused at a rate of 4 to 6 mg · kg1 · h1 during the operation and was discontinued immediately after the procedure. An arterial line was placed in an ear artery through a 22-gauge catheter for on-line monitoring of arterial blood pressure. Arterial blood PO2, PCO2, pH, bicarbonate concentration, hemoglobin concentration, and hematocrit were measured every 15 minutes for the purpose of adjusting ventilation to maintain a PCO2 of 36 ± 6 mm Hg. Blood pressure, electrocardiogram, and rectal temperature were recorded digitally (Hellige/Biosys, Vienna, Austria) during the intervention. A heating pad was used on each animal to maintain normal body temperature.
Motor evoked potentials
Two needle electrodes of an electric stimulator (Digitimer A, Welwyn Garden City, United Kingdom) for transcranial stimulation were fixed into the scalp on the dorsum of the nose and the midline over the occiput (anode). Additional electrodes of a second stimulator (Digitimer) for spinal stimulation were placed into 2 dorsal muscles on the left side close to lumbar vertebra 4 and spinal vertebra 3. A 4-channel electromyograph (Viking IV, Nicolet, Madison, Wis) was prepared for simultaneous recording of compound muscle action potentials from the superficial gluteal muscle, quadriceps muscle of the thigh, and biceps muscle of the thigh. Two separate single-impulse stimulations (150 µs) were released every minute, starting 2 minutes before crossclamping and ending when anesthesia was finished. Output levels for single-impulse stimulation up to 160 V for transcranial stimulation and 70 V for spinal stimulation were sufficient to achieve supramaximal stimulus; resulting amperage was 50 to 150 mA. Intervals for amplitude change (decrease or increase) by 75%, 50%, and 25% (with respect to the size of amplitudes gained 1 minute before crossclamping) were evaluated.
After sterile preparation a median laparotomy was made. The abdominal aorta was mobilized inferiorly to the left renal vein and down to the bifurcation. Each rabbit had anticoagulation with heparin (100 units/kg) before crossclamping. Aortic occlusion was obtained by placement of a vascular clamp above the aortic bifurcation followed by clamping of the aorta just below the left renal vein. All animals were subjected to 40 minutes of crossclamp time. Memantine was obtained from Merz (Dr H. Kolassa and Merz, Vienna, Austria).
After 40 minutes, the crossclamps were released and the laparotomy incision was closed. The animals were allowed to recover. Neurologic status was assessed with the Tarlov score (0, no movement; 1, slight movement; 2, sits alone; 3, weak hop; 4, normal hop) at 12, 24, 36, and 48 hours after the operation by an observer who had no previous knowledge of the experimental protocol.
15
All animals were killed 48 hours after the operation with a lethal injection of pentobarbital.
Histopathologic studies
All histopathologic materials were examined by a neuropathologist (P.B.) who was blinded both to the experimental design and to the identity of all animals. Excised segments of the vertebral column were fixed by immersion in 5% neutralized formalin. The spinal medulla was dissected and specimens were divided into central and external segments. Alcohol dehydration and paraffin embedding were performed with a Tissue-Tek 2000 (Miles Laboratories, Mishawaka, Ind) embedding device. Sections were cut 5 µm thick and stained with hematoxylin and eosin. Classification and quantification of anterior horn motor neurons were done in sections stained with hematoxylin and eosin. Perikarya were defined and counted and their frequencies were compared between the groups. The following morphologic criteria were used to define 4 groups of neurons: (1) In neurons with normal morphologic characteristics, perikarya are polygonal with cytoplasmic extensions. Centrally positioned nuclei are round, well defined, with loosely textured chromatin and prominent nucleolus. The cytoplasm stains violet; it contains ample Nissl substance as clumps of basophilic material. (2) In neurons with pyknosis, cytoplasm of pyknotic motor neurons is condensed and clefts separate the shrunken perikarya from the adjoining neuropil. Nuclei are reduced in size and irregularly outlined. The cytoplasm of pyknotic neurons is hyperchromatic, and its coloring changes to eosinophilic. (3) In neurons with chromatolysis, the perikaryon of chromatolytic motor neurons appears enlarged, ovoid rather than polygonal in shape. Cytoplasmic staining of these neurons is significantly reduced, causing an overall pale appearance. (4) In neurons with vacuolization, cellular shape is ovoid to round and Nissl substance is highly dispersed or not present. In addition, the nucleus is heavily disintegrated and largely devoid of chromatin.
Statistical analysis
Values are expressed as mean and SD or as the median and range. The differences among groups in Tarlov scores and in quantitative histologic findings were tested by nonparametric statistical analysis with the Mann-Whitney U test. Evoked potential data were analyzed with repeated measurement analysis of variance on the log-transformed data.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
This study demonstrates the efficacy of memantine in reducing the neurologic injury associated with prolonged aortic occlusion. The neuroprotective potency of this drug is presumably attributable to its ability to block calcium ion entry into the cell.
20
There was significant improvement in the clinical outcomes of rabbits that received memantine with respect to the control group. Both treated groups had higher Tarlov scores than did the control animals. Six of 8 animals treated with memantine before the operation had 100% recovery at 48 hours. These animals were standing without difficulty and were hopping normally. Animals that received intra-aortic memantine injections reached a median Tarlov score of 3 after 48 hours, without standing problems but with weak hopping. In contrast, control animals were paraplegic during the entire observation interval. Our results confirm the findings of Keilhoff and colleagues
21 that memantine is probably most efficient when applied before surgical intervention.
Histologic examination confirmed the ability of memantine to limit neuronal necrosis in the anterior horn motor neurons. Ischemia of the spinal cord in this experiment caused perikaryal swelling and vacuolization of anterior horn motor neurons. These morphologic changes developed after ischemia and caused the physiologic and clinical consequences observed after ischemic disturbance. Chromatolysis of Nissl substance, swelling and vacuolization of perikarya, and karyolysis were more frequently seen in the control group than in either group of treated animals, and these control animals showed severe functional impairment.
For monitoring nerve conductance ability, cortical somatosensory evoked potentials and different kinds of motor evoked potentials have been used as an additional method of detecting ischemia in an early and reversible stage to allow application or adjustment of protective strategies. Somatosensory evoked potentials are conducted mainly in the ascending sensory tracts of the posterior columns. Because the anterior horn motor neurons are especially sensitive to ischemia and receive their blood supply mainly from the anterior spinal artery, whereas the posterior columns are supplied through the posterior spinal artery, somatosensory evoked potentials may not always reflect ischemia of the motor system.
22 In our study spinal root stimulation potentials and transcranial motor evoked potentials were used. The latter showed gradual decrease under aortic occlusion but instant loss of amplitude when a bolus of ketamine, with or without xylazine, was administered. Our findings of various myogenic responses of transcranial motor evoked potentials depending on anesthesia depth is confirmed by other studies, which showed amplitudes of both transcranial motor evoked potentials and somatosensory evoked potentials to be affected by anesthetics.
23
Spinal root stimulation was associated with stable measurement conditions, allowing comparison of treatment groups with the control animals. Differences in times for reduction in amplitude during ischemia were not found among the 3 groups, indicating that loss of these recorded potentials did not reflect postoperative neurologic outcome. After release of the aortic crossclamp there was a trend in which both treated groups regained activity somewhat earlier than did the control group. Animals were only stimulated until the point at which they started to awake, however, so not all animals were included in this observation. This limitation precluded statistical analysis of these potentials. Further clinical investigations are required to determine the beneficial effects of memantine in preventing spinal cord injury after operations on the descending aorta. This NMDA blocker might be of interest because it is clinically used for the therapy of various cerebral disorders, such as Parkinson disease, spasticity, and chronic brain syndrome.
24
In conclusion, memantine significantly reduces the neurologic injury related to spinal cord ischemia. Although extrapolating the results to human beings is premature, systemic infusion of memantine may prove to be a simple yet effective means of spinal cord protection in descending thoracic and thoracoabdominal aneurysm repair.
| Appendix: Discussion |
|---|
|
|
|---|
Dr Ehrlich. It is a complex cascade when spinal cord ischemia is induced. First the ischemia initiates the release of excitatory amino acids, such as glutamate, aspartate, and glycine, from axons into the extracellular space. Postsynaptic NMDA receptors, especially for the amino acid glutamate, are activated. As a consequence, calcium channels are opened that further activate a series of enzymes, leading eventually to neuronal cell death.
Dr Pedro J. del Nido (Boston, Mass). One of the mechanisms through which delayed neuronal injury occurs is apoptosis, and that can occur 48 to 72 hours after the original insult. Did you look for evidence that this might actually be occurring in the spinal cord tissue? Also, did you actually look for glutamate concentration in the spinal cord fluid?
Dr Ehrlich. No, in this study we did not look specifically at apoptosis as a mechanism of cell death. I am aware that there is growing evidence, especially from Dr Kouchoukos' group, that apoptosis is among the mechanisms of delayed programmed cell death. With respect to glutamate concentrations in the spinal cord, it was difficult to obtain liquid from the spine in this animal model.
Dr Tadashi Omoto (Boston, Mass). Maybe it was 3 years ago in The Annals of Thoracic Surgery that a Japanese researcher from Fukuoka University reported on aortic crossclamping as long as 24 hours before, providing a late window on the preconditioning side of aortic crossclamping. Is this the same mechanism of excitatory amino acids? The research background was that before 24 hours after the aortic crossclamping of the descending aorta they showed improvement of the paraplegia. Do you think this mechanism will be similar to the excitatory amino acid cascade you described?
Dr Ehrlich. I cannot comment on this. We know from recent studies that there is an increase in all excitatory amino acids shortly after aortic occlusion. I am unsure of the influence preconditioning of the spinal cord could have on the release of glutamate.
Dr Fred A. Crawford, Jr (Charleston, SC). You had 2 experimental groups, 1 in which memantine was administered intra-aortically and 1 in which it was administered systemically. Is there any possibility that the 2 routes of administration could be additive, if the drug were to be given both ways at the same time?
Dr Ehrlich. Such a form of application could possibly be more powerful in preventing spinal cord ischemia.
Dr Tatu Juvonen (Oulu, Finland). I have a question regarding this molecule. Most of those glutamate receptor blockers are known to be extremely neurotoxic and to have serious side effects in clinical use. With respect to memantine, are there any potential concerns about clinical use?
Dr Ehrlich. I think that this is an important question because most of the excitatory amino acid blockers used so far, such as dextrorphan and MK-801, are neurotoxic in higher doses. Memantine, however, is already clinically used today in many countries as an antiparkinsonian drug. This drug is therefore of enormous interest with respect to clinical application for the future.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Saeki, M. Matsumoto, S. Kaneko, S. Tsuruta, Y. Jun Cui, K. Ohtake, K. Ishida, and T. Sakabe Is Intrathecal Magnesium Sulfate Safe and Protective Against Ischemic Spinal Cord Injury in Rabbits? Anesth. Analg., December 1, 2004; 99(6): 1805 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski and J. Bachet Pharmacological spinal cord protection with magnesium during replacement of the thoracic and thoracoabdominal aorta. Ann. Thorac. Surg., December 1, 2001; 72(6): 2180 - 2181. [Full Text] [PDF] |
||||
![]() |
H. Terada, T. Kazui, M. Takinami, K. Yamashita, N. Washiyama, and B. A. H. Muhammad Reduction of ischemic spinal cord injury by dextrorphan: Comparison of several methods of administration J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 979 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Juvonen, F. Biancari, J. Rimpilainen, V. Anttila, M. Pokela, V. Vainionpaa, P. Romsi, and K. Kiviluoma Determinants of mortality after hypothermic circulatory arrest in a chronic porcine model Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rimpilainen, M. Pokela, K. Kiviluoma, V. Vainionpaa, J. Hirvonen, P. Ohtonen, V. Jantti, V. Anttila, H. Heinonen, and T. Juvonen The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: A study in the chronic porcine model J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski, C. Heurteaux, H. Dupont, D. Rouelle, C. Widmann, and J. Mantz The Effects of FK506 on Neurologic and Histopathologic Outcome After Transient Spinal Cord Ischemia Induced by Aortic Cross-Clamping in Rats Anesth. Analg., May 1, 2001; 92(5): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Y.P. Wan, G. D. Angelini, A. J. Bryan, I. Ryder, and M. J. Underwood Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 203 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto Prevention of post-hypothermic circulatory arrest temporary neurologic deficits Ann. Thorac. Surg., November 1, 2000; 70(5): 1764 - 1765. [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski, C. Heurteaux, A. Mignon, J. Mantz, C. Widmann, J.-M. Desmonts, and M. Lazdunski Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole Eur. J. Cardiothorac. Surg., August 1, 2000; 18(2): 174 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Ross, J. A. Kern, J. J. Gangemi, C. R. St Laurent, K. S. Shockey, I. L. Kron, and C. G. Tribble HYPOTHERMIC RETROGRADE VENOUS PERFUSION WITH ADENOSINE COOLS THE SPINAL CORD AND REDUCES THE RISK OF PARAPLEGIA AFTER THORACIC AORTIC CLAMPING J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 588 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto A word of caution in extrapolating the riluzole spinal cord injury protective effects obtained in a rabbit model under ketamine anesthesia J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1156 - 1157. [Full Text] |
||||
![]() |
M. Ehrlich A word of caution in extrapolating the spinal cord protective effects of memantine obtained in a rabbit model under ketamine anesthesia J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 771 - 771. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |